期刊文献+

糖化血红蛋白在诊断2型糖尿病中的价值 被引量:5

下载PDF
导出
摘要 目的以葡萄糖耐量试验(OGTT)为金标准评价糖化血红蛋白(HbA1c)≥6.5%对于诊断2型糖尿病的可行性。方法对788名无糖尿病史的糖尿病高危患者,行口服75g葡萄糖耐量试验(OGTT),同时检测HbA1c。通过绘制受试者工作特征曲线(ROC曲线),分析HbA1c诊断糖尿病的敏感性和特异性。结果 OGTT试验达到诊断糖尿病标准者423例,检出率为54%;而HbA1c≥6.5%者362例(46%)。ROC曲线最佳切点6.35%,此时灵敏度为0.80,特异度0.89。HbA1c≥6.5%时,灵敏度为0.74,特异度0.93,阳性预测值(+PV)93%、阴性预测值(-PV)77%。Kappa检验显示HbA1c≥6.5%与OGTT标准的诊断结果一致性好(Kappa系数为0.68,P<0.01)。若增加HbA1c≥6.5%这一指标,糖尿病的检出率可增加至57%。结论 HbA1c≥6.5%具有很好的敏感性和特异性,可提高2型糖尿病的检出率。
出处 《心脑血管病防治》 2012年第4期306-308,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
基金 浙江省兰溪市科技局项目(编号:2011C06)
  • 相关文献

参考文献3

二级参考文献44

  • 1Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature, 2001, 414:782-787.
  • 2Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med, 2007, 24:451-463.
  • 3Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Praet, 2009.
  • 4Preventing chronic diseases: a vital investment. Geneva, World Health Organization, 2005.
  • 5Diabetes raellitus. Report of a WHO Expert Committee. Geneva, World Health Organization, 1965.
  • 6WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 646. Geneva, World Health Organization, 1980.
  • 7Diabetes Mellitus: Report of a WHO Study Group. Technical Report Series 727, Geneva, World Health Organization, 1985.
  • 8World Health Organization. Definition, Diagnosis and Classification of Diabeles Mellitus and its Complications. Part 1 : Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/ NCS/99.2 ed. Geneva, World Health Organization, 1999.
  • 9Definition and diagnosis of diabetes mellitns and inlermediale hyperglycaemia. Geneva, World Health Organization, 2006.
  • 10Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellilus. Diabeles Care, 1997, 20: 1183- 1197.

共引文献111

同被引文献40

  • 1荆爱玉,袁晓红,倪红艳,焦阳,梁曦,腾云,谢璇.糖化血红蛋白在诊断2型糖尿病中的价值[J].西安交通大学学报(医学版),2012,33(5):636-639. 被引量:22
  • 2周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:157
  • 3黄敬泽,王健.2型糖尿病糖化血红蛋白与全天不同时间血糖水平的关系[J].中国综合临床,2006,22(12):1101-1103. 被引量:42
  • 4Colosia AD,Palencia R,Khan S.Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies:a systematic literature review[J].Diabetes Metab Syndr Obes,2013;6(2):327-38.
  • 5Bendersky M,Sanchez R.Arterial hypertension in patients with type 2 diabetes mellitus[J].Rev Fac Cien Med Univ Nac Cordoba,2013;70(2):83-90.
  • 6Dunn CJ,Plosker GL,Keating GM,et al.Insulin glargine:an updated review of its use in the management of diabetes mellitus[J].Drugs,2006;66(12):1743.
  • 7Cho JH,Lee JH,Oh JA,et al.Complication reducing effect of the information technology-based diabetes management system on subjects with type 2diabetes[J].J Diabetes Sci Technol,2008;2(1):76-81.
  • 8Lu J,Zang J,Li H.Impact of three oral antidiabetic drugs on markers ofβ-cell function in patients with type 2 diabetes:a meta-analysis[J].PLo S One,2013;8(10):e76713.
  • 9Wang W,Bu R,Su Q,et al.Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy[J].Exp Opin Pharmacother,2011;12(18):2791-9.
  • 10Scott LJ.Repaglinide:a review of its use in type 2 diabetes mellitus[J].Drugs,2012;72(2):249-72.

引证文献5

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部